Metallopanstimulin as a marker for head and neck cancer

[1]  C. Hollenbeak,et al.  A New Assay to Screen for Head and Neck Squamous cell Carcinoma Using the Tumor Marker Metallopanstimulin , 2004, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[2]  O John Semmes,et al.  Serum Protein Profiles to Identify Head and Neck Cancer , 2004, Clinical Cancer Research.

[3]  D. Schuller,et al.  Role of the Physician Versus the Patient in the Detection of Recurrent Disease Following Treatment for Head and Neck Cancer , 2004, The Laryngoscope.

[4]  Taka-Aki Sato,et al.  Differential Expression of Ribosomal Proteins in Human Normal and Neoplastic Colorectum , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[5]  T. Carey,et al.  Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma , 2002, Head & neck.

[6]  T. Sasajima,et al.  Identification of metallopanstimulin-1 as a member of a tumor associated antigen in patients with breast cancer. , 2002, Cancer letters.

[7]  C. Hollenbeak,et al.  The cost‐effectiveness of fluorodeoxyglucose 18‐F positron emission tomography in the N0 neck , 2001, Cancer.

[8]  M. Schmidt,et al.  Urokinase-type plasminogen activator expression and proliferation stimulation in head and neck squamous cell carcinoma in vitro and in situ. , 2001, Archives of otolaryngology--head & neck surgery.

[9]  E. Tartour,et al.  Serum soluble interleukin–2 receptor concentrations as an independent prognostic marker in head and neck cancer , 2001, The Lancet.

[10]  P. Hamilton,et al.  Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents: implications for prevention and therapy of viral diseases and cancer. , 2001, Anticancer research.

[11]  H. Quon,et al.  Potential molecular prognostic markers in head and neck squamous cell carcinomas , 2001, Head and Neck.

[12]  H. Weidauer,et al.  Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapy , 2000, Head & neck.

[13]  B C Stack,et al.  Surveillance for recurrent head and neck cancer using positron emission tomography. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  V. Lowe,et al.  Overexpression of MPS antigens by squamous cell carcinomas of the head and neck: immunohistochemical and serological correlation with FDG positron emission tomography. , 1999, Anticancer research.

[15]  H. Naora,et al.  Involvement of ribosomal proteins in regulating cell growth and apoptosis: Translational modulation or recruitment for extraribosomal activity? , 1999, Immunology and cell biology.

[16]  P. Hamilton,et al.  Differential expression of metallopanstimulin/S27 ribosomal protein in melanocytic lesions of the skin , 1997, Journal of cutaneous pathology.

[17]  D. Ganger,et al.  Metallopanstimulin is overexpressed in a patient with colonic carcinoma. , 1997, Anticancer research.

[18]  J. Fletcher,et al.  Expression of metallopanstimulin and oncogenesis in human prostatic carcinoma. , 1997, Anticancer research.

[19]  I. Wool,et al.  The primary structures of rat ribosomal proteins S3a (the V-Fos transformation effector) and of S3b. , 1996, Biochemical and biophysical research communications.

[20]  I. Wool,et al.  The primary structure of rat ribosomal protein L10: relationship to a Jun-binding protein and to a putative Wilms' tumor suppressor. , 1996, Biochemical and biophysical research communications.

[21]  Fernandez-Pol Ja,et al.  Metallopanstimulin as a novel tumor marker in sera of patients with various types of common cancers: implications for prevention and therapy. , 1996 .

[22]  I. Wool.  Extraribosomal functions of ribosomal proteins. , 1996, Trends in biochemical sciences.

[23]  I. Wool,et al.  Structure and evolution of mammalian ribosomal proteins. , 1995, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[24]  P. Hamilton,et al.  Metallopanstimulin gene product produced in a baculovirus expression system is a nuclear phosphoprotein that binds to DNA. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[25]  P. Hamilton,et al.  A growth factor-inducible gene encodes a novel nuclear protein with zinc finger structure. , 1993, The Journal of biological chemistry.

[26]  B. Adam,et al.  Identification of patients with head and neck cancer using serum protein profiles. , 2004, Archives of otolaryngology--head & neck surgery.

[27]  R. Carlson.  NCCN breast cancer clinical practice guidelines in oncology: an update. , 2003, Journal of the National Comprehensive Cancer Network : JNCCN.

[28]  D. Ganger,et al.  Differential expression of metallopanstimulin/S27 ribosomal protein in hepatic regeneration and neoplasia. , 2001, Cancer detection and prevention.

[29]  J A Fernandez-Pol,et al.  Metallopanstimulin as a novel tumor marker in sera of patients with various types of common cancers: implications for prevention and therapy. , 1996, Anticancer research.

[30]  Brady S.K Choksi.  The Management of Head and Neck Cancer , 1984, Springer Berlin Heidelberg.